DIP2C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.062200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.689200E-01
Normal-vs-Stage2
7.924000E-01
Normal-vs-Stage3
5.297800E-01
Normal-vs-Stage4
5.629400E-01
Stage1-vs-Stage2
8.784400E-01
Stage1-vs-Stage3
3.599800E-01
Stage1-vs-Stage4
4.188200E-01
Stage2-vs-Stage3
5.423800E-01
Stage2-vs-Stage4
1.132610E-01
Stage3-vs-Stage4
2.345200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.925800E-01
Normal-vs-AfricanAmerican
7.289400E-01
Normal-vs-Asian
5.684400E-01
Caucasian-vs-AfricanAmerican
4.800400E-01
Caucasian-vs-Asian
3.208600E-01
AfricanAmerican-vs-Asian
2.306800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.899600E-01
Normal-vs-Female
9.415800E-01
Male-vs-Female
7.441000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.847600E-01
Normal-vs-Age(41-60Yrs)
7.449800E-01
Normal-vs-Age(61-80Yrs)
7.662600E-01
Normal-vs-Age(81-100Yrs)
3.656400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.713770E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.678400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.332400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.491600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.034260E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.393200E-01
Normal-vs-Daily Drinker
4.175200E-01
Normal-vs-Weekly Drinker
9.365200E-01
Normal-vs-Occasional Drinker
7.540600E-01
Normal-vs-Social Drinker
7.842800E-01
Non Drinker-vs-Daily Drinker
9.558200E-01
Non Drinker-vs-Weekly Drinker
1.408180E-01
Non Drinker-vs-Occasional Drinker
1.368240E-01
Non Drinker-vs-Social Drinker
1.179200E-01
Daily Drinker-vs-Weekly Drinker
1.613390E-01
Daily Drinker-vs-Occasional Drinker
1.430360E-01
Daily Drinker-vs-Social Drinker
1.253220E-01
Weekly Drinker-vs-Occasional Drinker
5.652600E-01
Weekly Drinker-vs-Social Drinker
7.087600E-01
Occasional Drinker-vs-Social Drinker
8.042000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.530400E-01
Normal-vs-Grade 2
4.069800E-02
Normal-vs-Grade 3
5.985800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.329000E-01
Grade 1-vs-Grade 3
6.463000E-01
Grade 1-vs-Grade 4
2.530400E-01
Grade 2-vs-Grade 3
7.813800E-01
Grade 2-vs-Grade 4
4.069800E-02
Grade 3-vs-Grade 4
5.985800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.125600E-01
Normal-vs-NonDiabetic
7.790200E-01
Diabetic-vs-NonDiabetic
7.992600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.749200E-01
Normal-vs-NoPancreatitis
8.185400E-01
Pancreatitis-vs-NoPancreatitis
4.239200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.709800E-01
Normal-vs-N1
8.265400E-01
N0-vs-N1
9.447200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.147000E-01
Normal-vs-TP53-NonMutant
9.948600E-01
TP53-Mutant-vs-TP53-NonMutant
4.710400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
